Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FN4GQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,654
Award facts
- Contract value 100% obligated
- $8,653.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $8,653.84 for Zepbound (tirzepatide) 15 mg/0.5 mL pens. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs worldwide.
This delivery order supports the Defense Logistics Agency's mission to supply critical medical commodities across the federal healthcare system, including the Defense Health Agency and other government healthcare customers. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements, from specialty medications to vaccines and medical supplies across multiple therapeutic domains. The firm fixed-price structure and rapid completion timeline reflect the expedited nature of this pharmaceutical procurement for federal medical operations.
Quick answers
Who was awarded contract SPE2DB25FN4GQ?
SPE2DB25FN4GQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FN4GQ worth?
The government has obligated $8,654 on SPE2DB25FN4GQ.
Is contract SPE2DB25FN4GQ an order under another contract?
Yes. SPE2DB25FN4GQ is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN4GQ competed?
The extent of competition for SPE2DB25FN4GQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award